Profile for Rigel Pharmaceuticals Inc. (RIGL)

$ 2.46   -0.06 (-2.38%) Volume: 3.95m 4:00 PM EDT 6-Aug-2020
After Hours:  $ 2.48   0.02 (+0.81%) Volume: 27.48k 4:42 PM EDT 6-Aug-2020
Business Description:
Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company. It discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases.
Address: 1180 Veterans Boulevard, South San Francisco, CA, USA, 94080
Telephone: +1 650 624-1100 Website:
Facsimile: +1 650 624-1101 Email: [email protected]
CEO: Raul R. Rodriguez
Employees: 163 Market Cap: 414.68m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1034842
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)